The application of sulfur-containing peptides in drug discovery

作者: Jiaoyan Zhao , Xuefeng Jiang

DOI: 10.1016/J.CCLET.2018.05.026

关键词: ChemistryDrug discoverySulfur containingComputational biologyPeptide

摘要: Abstract In recent decades, peptides as potential drugs were more and explored with the development of non-oral medicine. There into, sulfur-containing peptide is one most popular aspects in due to introduction sulfur atoms leading unique properties. The purpose present review focus on discovery various particular emphasis their pharmacological mechanisms. This organized according structures peptides.

参考文章(78)
CELIA HENRY, TAKING AIM AT MELANOMA Chemical & Engineering News. ,vol. 83, pp. 17- ,(2005) , 10.1021/CEN-V083N025.P017
Marc Thibonnier, Liliana N. Berti-Mattera, Nickolai Dulin, Doreen M. Conarty, Rafael Mattera, Signal transduction pathways of the human V1-vascular, V2-renal, V3-pituitary vasopressin and oxytocin receptors. Progress in Brain Research. ,vol. 119, pp. 147- 161 ,(1998) , 10.1016/S0079-6123(08)61568-X
Peter W. Latham, Therapeutic peptides revisited Nature Biotechnology. ,vol. 17, pp. 755- 757 ,(1999) , 10.1038/11686
Angelo DeMezza, George P. Sartiano, Sallie S. Boggs, Minimal bone marrow damage in mice given bleomycin. Cancer Research. ,vol. 34, pp. 1938- 1942 ,(1974)
M. Manning, A. Misicka, A. Olma, K. Bankowski, S. Stoev, B. Chini, T. Durroux, B. Mouillac, M. Corbani, G. Guillon, Oxytocin and Vasopressin Agonists and Antagonists as Research Tools and Potential Therapeutics Journal of Neuroendocrinology. ,vol. 24, pp. 609- 628 ,(2012) , 10.1111/J.1365-2826.2012.02303.X
Fan Zhao, Man Lung Ma, Bing Xu, Molecular hydrogels of therapeutic agents Chemical Society Reviews. ,vol. 38, pp. 883- 891 ,(2009) , 10.1039/B806410P
Mario Cozzolino, James Tomlinson, Liron Walsh, Antonio Bellasi, Emerging drugs for secondary hyperparathyroidism Expert Opinion on Emerging Drugs. ,vol. 20, pp. 197- 208 ,(2015) , 10.1517/14728214.2015.1018177
A A Mathias, P German, B P Murray, L Wei, A Jain, S West, D Warren, J Hui, B P Kearney, Pharmacokinetics and pharmacodynamics of GS-9350: a novel pharmacokinetic enhancer without anti-HIV activity. Clinical Pharmacology & Therapeutics. ,vol. 87, pp. 322- 329 ,(2010) , 10.1038/CLPT.2009.228